AMORPHOPHALLUS PAEONIIFOLIUS (ARACEAE): A NUTRACEUTICAL FOR FOOD DISORDERS, NOVEL BACTERIAL & VIRAL INFECTIONS

被引：0
|
作者：
Swain, Jugajyoti [1 ]
Devi, Rajkumari Supriya [2 ]
Kumar, Sanjeet [2 ]
Camelo Antunes, Lorena Lana [3 ]
Biswal, Susanta K. [4 ]
Jena, Padan Kumar [1 ]
机构：
[1] Ravenshaw Univ, Dept Bot, Cuttack, India
[2] Ambika Prasad Res Fdn, Biodivers & Conservat Lab, Odihsa, India
[3] Univ Fed Goias, Biol Sci Inst, Bot Dept, BR-74001970 Goiania, Go, Brazil
[4] Centurion Univ Technol & Management, Sch Appl Sci, R Sitapur, Odisha, India
来源：
CARPATHIAN JOURNAL OF FOOD SCIENCE AND TECHNOLOGY | 2022年 / 14卷 / 01期
关键词：
Antioxidant activity; Wild Tubers; Amorphophallus; Coronavirus; Ethnobotany; Food disorders; Secondary metabolites; Viral infections; Anti-microbial resistance; CYTOTOXIC ACTIVITIES; PHENOLIC CONTENT; TUBER; ANTIBACTERIAL; ANTIFUNGAL; OXALATE; PROSTAGLANDINS; COLITIS; GREEN;
D O I：
10.34302/crpjfst/2022.14.1.10
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
Amorphophallus paeoniifolius is a very common tuber plant having diverse secondary metabolites and palatability levels. Keeping the problems of food shortage & novel infectious diseases throughout the world, an attempt has been made through fieldworks during 2009 to 2020 to gather the information on its ethnobotany, bioactive compounds from lab work and pharmacological properties from secondary sources to make it future nutraceutical against food disorders & novel microbial diseases. The tuber is used as food and medicines, it is rich with primary & secondary metabolites and its extracts are used to treat various infectious diseases. The compounds present in the species have potential to make novel drugs against present health problems throughout the world. The present study highlights the importance of wild tuberous plants in mitigation of food shortage, food disorders, anti-microbial resistance, novel bacterial & viral diseases like MDR-TB and COVID-19.
引用
收藏
页码：118 / 136
页数：19
相关论文
共 14 条
  • [1] Aptamers: Novel Molecules as Diagnostic Markers in Bacterial and Viral Infections?
    Zimbres, Flavia M.
    Tarnok, Attila
    Ulrich, Henning
    Wrenger, Carsten
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [2] A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections
    Oved, Kfir
    Cohen, Asi
    Boico, Olga
    Navon, Roy
    Friedman, Tom
    Etshtein, Liat
    Kriger, Or
    Bamberger, Ellen
    Fonar, Yura
    Yacobov, Renata
    Wolchinsky, Ron
    Denkberg, Galit
    Dotan, Yaniv
    Hochberg, Amit
    Reiter, Yoram
    Grupper, Moti
    Srugo, Isaac
    Feigin, Paul
    Gorfine, Malka
    Chistyakov, Irina
    Dagan, Ron
    Klein, Adi
    Potasman, Israel
    Eden, Eran
    PLOS ONE, 2015, 10 (03):
  • [3] Editorial: Novel approaches to prevention, diagnosis, and treatment of bacterial and viral infections of clinical relevance
    Leanse, Leon G.
    Trombetta, Claudia Maria
    Carnell, George W.
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [4] Distinguishing viral and bacterial infections made easy through the food and drug administration approved technology-assisted diagnosis
    Mahajan, Rajiv
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2021, 11 (04) : 205 - 205
  • [5] A Novel Combination of Host Protein Biomarkers to Distinguish Bacterial From Viral Infections in Febrile Children in Emergency Care
    Tan, Chantal D.
    van den Broek, Bryan S.
    Womersley, Rebecca
    Kaforou, Myrsini N.
    Hagedoorn, Nienke
    van der Flier, Michiel
    Jackson, Heather A.
    Moll, Henriette
    Snijder, Rozemarijn I.
    de Jonge, Marien L.
    Vermont, Clementien
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (07) : E235 - E242
  • [6] Clinical utility of cerebrospinal fluid vitamin D-binding protein as a novel biomarker for the diagnosis of viral and bacterial CNS infections
    Kim, Young Jin
    Le, Huong Giang
    Na, Byoung-Kuk
    Kim, Bo Gyu
    Jung, Youn-Kwan
    Kim, Mutbyul
    Kang, Heeyoung
    Cho, Min-Chul
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [7] Clinical utility of cerebrospinal fluid vitamin D-binding protein as a novel biomarker for the diagnosis of viral and bacterial CNS infections
    Young Jin Kim
    Hương Giang Lê
    Byoung-Kuk Na
    Bo Gyu Kim
    Youn-Kwan Jung
    Mutbyul Kim
    Heeyoung Kang
    Min-Chul Cho
    BMC Infectious Diseases, 21
  • [8] A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections
    Stein, Michal
    Lipman-Arens, Shelly
    Oved, Kfir
    Cohen, Asi
    Bamberger, Ellen
    Navon, Roy
    Boico, Olga
    Friedman, Tom
    Etshtein, Liat
    Paz, Meital
    Gottlieb, Tanya M.
    Kriger, Or
    Fonar, Yura
    Pri-Or, Ester
    Yacobov, Renata
    Dotan, Yaniv
    Hochberg, Amit
    Grupper, Moti
    Chistyakov, Irina
    Potasman, Israel
    Srugo, Isaac
    Eden, Eran
    Klein, Adi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 90 (03) : 206 - 213
  • [9] IMMUNOMAX FOR THE THERAPY OF DISORDERS OF THE UROGENITAL TRACT A NOVEL IMMUNSTIMULATORY THERAPY TO OBTAIN RELIEVE IN BACTERIAL INFECTIONS PROSTATITS AND IN PROSTATE CARCINOMA
    Ataullakhanov, Ravshan
    Bauer, Hartwig
    Holms, Rupert
    Bessler, Wolfgang G.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 235 - 235
  • [10] Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs
    Jacka, Brendan P.
    Phipps, Emily
    Marshall, Brandon D. L.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 83
12